Efloxate
Chemical compound
- C01DX13 (WHO)
- ethyl 2-[(4-oxo-2-phenyl-4H-chromen-7-yl)oxy]acetate
- 119-41-5 Y
- 8395
- 8089
- CZU6V3902K
- ChEMBL1349073
- DTXSID3048736
- Interactive image
- CCOC(=O)COc1ccc2c(=O)cc(oc2c1)c3ccccc3
InChI
- InChI=1S/C19H16O5/c1-2-22-19(21)12-23-14-8-9-15-16(20)11-17(24-18(15)10-14)13-6-4-3-5-7-13/h3-11H,2,12H2,1H3
- Key:ZVXBAHLOGZCFTP-UHFFFAOYSA-N
Efloxate is a vasodilator.[1]
References
- ^ Tomasi AM, Masoni A (August 1977). "[Clinical research on the therapeutic efficacy and tolerance of long-acting efloxate in angina pectoris]". La Clinica Terapeutica (in Italian). 82 (3): 227–41. PMID 334448.
- v
- t
- e
Vasodilators used in cardiac diseases (C01D)
- Nitroglycerin #
- Isosorbide dinitrate #
- Isosorbide mononitrate
- Itramin tosilate
- Linsidomine
- Molsidomine
- Nicorandil
- Pentaerythritol tetranitrate
- Propatylnitrate
- Tenitramine
- Trolnitrate
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e